Objective-To evaluate the role of nociception in patients with angina despite normal coronary angiograms and to investigate whether any abnormality is confined to visceral or somatosensory perception. Methods-Perception, pain threshold, and brain evoked potentials to nociceptive electrical stimuli of the oesophageal mucosa and the sternal skin were investigated in 10 patients who had angina but normal coronary angiograms, no other signs of cardiac disease, and normal upper endoscopy. Controls were 10 healthy volunteers. The peaks of the evoked potential signal were designated N for negative deflections and P for positive. Numbers were given to the peaks in order of appearance after the stimulus. The peak to peak amplitudes (P1/Ni, N1/P2) were measured in uV.
Results-(1) Angina pectoris was provoked in seven patients following continuous oesophageal stimulation. (2) Distant projection of pain occurred after continuous electrical stimulation of the oesophagus in four patients and in no controls. (3) Patients had higher oesophageal pain thresholds (median 16-3 mA v 7-3 mA, P = 0.02) to repeated stimuli than controls, whereas the values did not differ with respect to the skin. There were no intergroup differences in thresholds to single stimuli. (4) Patients had substantially reduced brain evoked potential amplitudes after both single oesophageal (P1/Ni, median values: 7'2 MV, controls: 29-0 uV; N1/P2: gV, controls: 66-0 ,uV; P < 0-001 for both) and skin (N1/P2: ,V; controls: 76-0 MV; P < 0.001) stimuli despite the similar pain thresholds. Conclusion-Central nervous system responses to visceral and somatosensory nociceptive input are altered in patients who have angina despite normal coronary angiograms.
(Heart 1996;75:436-441) Keywords : angina pectoris; electrical stimulation; nociception; stimulus-response Several pathophysiological explanations have been suggested for the pain syndrome in patients with angina and normal coronary angiograms: abnormal cardiac nociception following intracardiac catheter manipulation' 2 or intracoronary adenosine infusion3; reduced capacity of minor coronary vessels to dilate4; a generally elevated sympathetic activation5 6; gastrooesophageal reflux7 and oesophageal motility disturbances8; a combination of oesophageal and cardiac aetiology9; insulin resistance'0; psychiatric illness' 1-13; and musculo-skeletal disorders of the chest.'4-16 A general abnormality of nociception could incorporate many of the results from previous studies'7 and recently this hypothesis has found support in a clinical trial where imipramine, a cyclic antidepressant with general antinociceptive properties, given to patients with angina and normal coronary angiograms resulted in a reduction of pain episodes. 18 In order to evaluate the role of nociception further and to investigate whether any abnormalities are confined to visceral or somatosensory perception, we employed an experimental model of electrical stimulation of the oesophageal mucosa and the prestemal skin in patients with angina despite normal coronary angiograms and in healthy controls. The applied stimuli were evaluated by brain evoked potentials, which facilitates a quantitative measure of the central responses. ' Hz stimulation (each pulse of 1 ms duration) was applied and the stimulus intensity was slowly increased until the subject asked for termination due to discomfort. The persons were asked to describe the sensations after single and continuous stimulation but they were not provided with descriptive words. Thereafter the patients were asked to answer "yes" or "no" depending on whether the sensations were similar to their usual episodes of angina. Cutaneous stimuli were delivered through a surface electrode (Dantec 13L22, Copenhagen, Denmark) with 23 mm between the two saline soaked felt tips (3 mm diameter) placed at the sternum 12 cm distal to the jugular incisure. Cutaneous stimuli characteristics were identical to the oesophageal stimuli (short trains of square wave pulses, five per stimulus each of 1 ms duration, 4 ms apart).
All thresholds were determined as the mean of two measurements. EVOKED 
POTENTIALS
Evoked vertex potentials were assessed by stimulating the oesophageal mucosa and the sternal skin at amperages 1-3 times the previously determined pain thresholds. The evoked potentials were recorded with a platinum needle electrode (Disa 25C04, Copenhagen, Denmark) inserted at C, with reference to linked earlobes as previously described. 19 20 The electroencephalogram was filtered by a second order filter (0-5-12 Hz), amplified, and sampled by a computer at 64 Hz. On average 16 stimuli were used since this is sufficient to obtain an acceptable signal to noise ratio.2' A test stimulus was delivered before each series, and 2 s before each stimulus the subjects received an auditory warning stimulus to minimise variability.24 The subjects were asked to keep their eyes open, and eye movements which could contaminate the evoked potentials were monitored continuously. The peaks of the evoked potential signal were designated N for negative deflections and P for positive. Numbers were given to the peaks in order of appearance after the stimulus. The P1, Ni, and P2 peaks were determined independently by two blinded observers. The peak to peak amplitudes (P1fN1, N1/P2) in pV and latencies of P1, Ni and P2 in ms with respect to trigger onset were measured by computer.
STATISTICS
The Mann-Whitney test for unpaired observations was used to compare median values between groups. Bivariate correlations were evaluated by Pearson's least square regression. P < 005 was considered significant.
ETHICS AND SAFETY
The study was approved by the local ethics committee. Written informed consent was obtained from all subjects and the entire study was carried out in a cardiac clinic with continuous monitoring by electrocardiogram, intravenous access established, and resuscitation stand by.
Results
There was no significant difference in age between patients and controls. All subjects completed the study. One patient had atrial capture during continuous oesophageal stimu- 12-2 (9-8-21-7) ** 53-4 (33-7-98-9) N, negative; P, positive, *P < 0-05; **P < 0-001. that differed between patients and controls was that of the P2 peak following sternal stimulation (table 2) .
Discussion
The results of the present study suggest that patients with angina, despite normal coronary angiograms, have altered processing of nociceptive inputs. Despite similar pain thresholds the evoked potential amplitudes following nociceptive electrical stimulation of both the oesophagus and the skin were substantially lower in patients than in controls. Only a few studies of evoked potential responses have been carried out in patients with visceral pain. Reduced evoked potential amplitudes have been found after nociceptive somatosensory stimulation of chronic cancer pain patients, with the low amplitudes apparently restricted to input from pain affected regions.25 Reduced evoked potentials were also described following non-nociceptive oesophageal balloon distension in patients with angina-like chest pain, in a study where the mean age of the control group was significantly lower than that of the patient group.26 By contrast, a study of patients with chronic burning pain in the mouth showed increased brain evoked potential amplitudes to intraoral pain stimulation compared to a matched control group.27 Using positron emission tomography, Rosen et al recently showed that dobutamine-induced angina in patients with coronary artery disease resulted in thalamic and frontal cortical activity during angina but only the thalamic activity persisted through the postangina scan.28 They concluded that the thalamus may act as a gate to afferent pain signals. A strong thalamic gate in patients with angina and normal coronary angiograms could also contribute to explaining the reduced vertex evoked potentials of the present study.
Brain evoked potentials are generally regarded as the summated electrical fields of a large number of neuronal membranes acting in synchrony.29 Age, neuropathy, and the level of arousal are critical factors for the amplitudes and latencies of brain evoked potentials."0-2 In the present study there were no differences in age (or sex) between patients and controls, no subjects had endocrinological disorders or neuropathy, and in order to reduce and standardise arousal, test stimuli were applied to make subjects familiar with the study regimen. Amplitude increases of the evoked potential responses could be due to additional recruitment of non-nociceptive nerve fibres.29 However, there is no reason to believe that such sources of error might influence the results in a specific direction when comparing findings of patients and controls. We have previously shown that there was no systematic difference in evoked potential latency values following oesophageal stimulation on two occasions six months apart.20 However, in that study we found a significantly higher amplitude in the first compared with the second measurement, which could reflect the fact that subjects were more aroused at their first session. In the present study no subjects had any previous experience with this kind of investigation. Previous studies have shown positive correlations between evoked potential amplitudes and the intensity of pain, and little relation between amplitudes and stimulus intensity (cited in 29) as in the present study.
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